Eternity in Medical Information -- Medisurf


Search \| Web Directory, News, Variable useful Information, PubMed In Medine, All

Category Select :

Items 1 ~ 20 of 25628, Page 1 of 1282

1. Abbott to Present at J.P. Morgan Healthcare Conference

ABBOTT PARK, Ill., Dec. 11, 2018 /PRNewswire/ --?Abbott (NYSE: ABT)?will present at the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 8, 2019. Brian Yoor, executive vice president of finance and Chief Financial Officer, will present at the conference at 11 a.m. Central time.

12/11/2018 Abbott

2. American Academy of Ophthalmology Calls on States to Maintain High Safety Standards for Surgical Eye Care

Nation’s eye physicians and surgeons support executive branch’s emphasis on patient safety as state lawmakers weigh scope-of-practice expansion

12/10/2018 American Academy of Ophthalmology

3. AAOS Encouraged by Administration’s Plan to Promote Healthcare Competition

12/06/2018 American Academy of Orthopaedic Surgeons

4. Youth Football Changes Nerve Fibers in Brain

Repetitive blows to the head can result in changes in the brains of youth football players

11/29/2018 Radiological Society of North America

5. Snoring Poses Greater Cardiac Risk to Women

Obstructive sleep apnea and snoring may affect cardiac function in women differently than in men.

11/29/2018 Radiological Society of North America

6. FDA warns company for selling e-liquids that resemble kid-friendly foods as part of the agency’s ongoing Youth Tobacco Prevention Plan

11/29/2018 U.S. FOOD & DRUG ADMINISTRATION

7. FDA approves first biosimilar for treatment of adult patients with non-Hodgkin’s lymphoma

The agency has now approved 15 biosimilars and is advancing new policies to improve the efficiency of biosimilar development and review

11/28/2018 U.S. FOOD & DRUG ADMINISTRATION

8. FDA approves treatment for adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a certain genetic mutation

The U.S. Food and Drug Administration today approved Xospata (gilteritinib) tablets for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with...

11/28/2018 U.S. FOOD & DRUG ADMINISTRATION

9. FDA approves first treatment for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder

The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults...

11/28/2018 U.S. FOOD & DRUG ADMINISTRATION

10. FDA Approves Vitrakvi (Larotrectinib) for Tumors With Certain Genetic Change

For the second time, the US Food and Drug Administration (FDA) has approved a drug to treat tumors with a specific genetic change regardless of the type of cancer. Vitrakvi (larotrectinib) is for adults and children with solid tumors that test positive for NTRK genes, which can help cancerous tumors grow.

11/28/2018 American Cancer Society

11. Can Coffee Lower Cancer Risk?

What’s the latest about the health effects of that morning-boosting, belly-warming cup of rich, creamy coffee? We’ll tell you what the research says about coffee and your cancer risk.

11/28/2018 American Cancer Society

12. European Commission Approves Merck’s DELSTRIGO™ (doravirine / lamivudine / tenofovir disoproxil fumarate), a Once-Daily Fixed-Dose Combination Tablet as a Complete Regimen and PIFELTRO™ (doravirine), an NNRTI, Both for the Treatment of HIV-1 in...

Approvals Based on Findings from the Pivotal Phase 3 DRIVE-AHEAD and DRIVE-FORWARD Trials Evaluating the Efficacy and Safety of DELSTRIGO and PIFELTRO Through 96 Weeks

11/28/2018 MERCK

13. James P. Borgstede, M.D., Named President-Elect of the RSNA Board

CHICAGO ? James P. Borgstede, M.D., was named president-elect of the Radiological Society of North America (RSNA) Board of Directors today at the Society''s annual meeting in Chicago.